Fig. 4From: Safety and tolerability of repeated doses of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a systematic review and an aggregated data meta-analysis of randomized controlled trialsComparison of serious adverse events between DP and SP. RR Risk Ratio, CI = Confidence Interval, DP Dihydroartemisinin-Piperaquine, SP Sulfadoxine- pyrimethamineBack to article page